Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm's ...

U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...

Lung cancer, the second-most common cancer in the U.S., is often associated with smoking — but even those who have never had ...

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like ...